The design and reporting of sham acupuncture and its association with the efficacy in acupuncture randomized controlled trials for migraine
Abstract
Background: In current trials of acupuncture for migraine treatment, the heterogeneity in therapeutic outcomes has been noted, which may be closely tied to the use of diverse sham acupuncture designs. This paper aims to evaluate the reporting quality of sham acupuncture and assess the potential impact of the consistency for intervention procedure between sham and true acupuncture groups on efficacy size in randomized controlled trials (RCTs) for migraine.
Methods: RCTs with sham acupuncture as a control in migraine were searched in four English and four Chinese databases from inception to May 2024. Based on the SHARE checklist, the distribution of reported items and reporting rates were investigated. The meta-regressions were conducted to assess the potential impact of the consistency of intervention procedures between sham and true acupuncture groups on efficacy size of acupuncture for migraine.
Results: Evaluation of the 46 included studies revealed that a significant proportion of item descriptions were incomplete, such as the information informed or explained to patients (Item 5, 4(8.70%)), relevant operation training information (Item 6.2, 6(13.04%)) and Communication between practitioner and patient (Item 3.3, 8(17.39%)). Meanwhile, the Basic manipulation techniques (β=-0.76), Times of manipulation (β=-0.34), Time point of manipulation (β=-0.34), Frequency of manipulation (β=-0.34) and Duration of manipulation per time (β=-0.34) significantly impact efficacy of…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.